Sargent Bickham Lagudis LLC Gsk PLC Transaction History

Sargent Bickham Lagudis LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Sep 07, 2021	SELL	$37.87 - $43.58 $8,596 - $9,892	-227 Closed	0 $0
Q2 2019 Sep 13, 2021	SELL	$39.4 - $42.7 $20,763 - $22,502	-527 Reduced 69.89%	227 $9,000
Q1 2019 Sep 13, 2021	SELL	$38.57 - $42.69 $3,702 - $4,098	-96 Reduced 11.29%	754 $32,000
Q4 2018 Sep 13, 2021	BUY	$37.8 - $42.69 $8,883 - $10,032	235 Added 38.21%	850 $32,000
Q3 2018 Sep 13, 2021	BUY	$39.75 - $42.69 $278 - $298	7 Added 1.15%	615 $25,000
Q2 2018 Sep 13, 2021	BUY	$39.61 - $42.76 $316 - $342	8 Added 1.33%	608 $25,000
Q1 2018 Sep 13, 2021	BUY	$36.18 - $40.15 $18,090 - $20,075	500 Added 500.0%	600 $23,000
Q4 2017 Sep 13, 2021	SELL	$35.34 - $41.9 $17,670 - $20,950	-500 Reduced 83.33%	100 $4,000
Q4 2016 Sep 13, 2021	SELL	N/A	-374 Reduced 38.4%	600 $23,000
Q3 2016 Sep 13, 2021	BUY	N/A	242 Added 33.06%	974 $42,000
Q2 2016 Sep 07, 2021	BUY	N/A	390 Added 114.04%	732 $32,000
Q1 2016 Sep 07, 2021	BUY	N/A	342	342 $14,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.